Effect of neurotrophic factor, MDP, on rats' nerve regeneration

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRAS DIVULG CIENTIFICA
Citação
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.44, n.4, p.327-331, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Our objective was to determine the immune-modulating effects of the neurotrophic factor N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) on median nerve regeneration in rats. We used male Wistar rats (120-140 days of age, weighing 250-332 g) and compared the results of three different techniques of nerve repair: 1) epineural neurorrhaphy using sutures alone (group S - 10 rats), 2) epineural neurorrhaphy using sutures plus fibrin tissue adhesive (FTA; group SF - 20 rats), and 3) sutures plus FTA, with MDP added to the FTA (group SFM - 20 rats). Functional assessments using the grasp test were performed weekly for 12 weeks to identify recovery of flexor muscle function in the fingers secondary to median nerve regeneration. Histological analysis was also utilized. The total number and diameter of myelinated fibers were determined in each proximal and distal nerve segment. Two indices, reported as percentage, were calculated from these parameters, namely, the regeneration index and the diameter change index. By the 8th week, superiority of group SFM over group S became apparent in the grasping test (P = 0.005). By the 12th week, rats that had received MDP were superior in the grasping test compared to both group S (P < 0.001) and group SF (P = 0.001). Moreover, group SF was better in the grasping test than group S (P = 0.014). However, no significant differences between groups were identified by histological analysis. In the present study, rats that had received MDP obtained better function, in the absence of any significant histological differences.
Palavras-chave
Grasping test, Neurotrophic factor, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP)
Referências
  1. Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5
  2. Hikawa N, 1996, CELL MOL NEUROBIOL, V16, P517, DOI 10.1007/BF02150231
  3. Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
  4. DELLON AL, 1989, MICROSURG, V10, P220, DOI 10.1002/micr.1920100316
  5. Wolfert MA, 2002, J BIOL CHEM, V277, P39179, DOI 10.1074/jbc.M204885200
  6. Shamash S, 2002, J NEUROSCI, V22, P3052
  7. BERTELLI JA, 1995, J NEUROSCI METH, V58, P151, DOI 10.1016/0165-0270(94)00169-H
  8. Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x
  9. BENFRECH E, 1989, Annales de Chirurgie de la Main, V8, P296, DOI 10.1016/S0753-9053(89)80020-1
  10. BodineFowler SC, 1997, MUSCLE NERVE, V20, P29, DOI 10.1002/(SICI)1097-4598(199701)20:1<29::AID-MUS4>3.0.CO;2-J
  11. Fukuyama R, 1998, RESTOR NEUROL NEUROS, V13, P213
  12. Inoe AP, 2007, PESQUISA VET BRASIL, V27, P363, DOI 10.1590/S0100-736X2007000900002
  13. Martins RS, 2005, SURG NEUROL S1, V64, P10, DOI 10.1016/J.SURNEU.2005.04.022
  14. MOONIS M, 1992, INDIAN J BIOCHEM BIO, V29, P115
  15. MOY OJ, 1988, J HAND SURG-AM, V13A, P273
  16. PARANT MA, 1992, ADV EXP MED BIOL, V319, P175
  17. Ramon Y., 1928, DEGENERATION REGENER
  18. SMAHEL J, 1987, Journal of Reconstructive Microsurgery, V3, P211, DOI 10.1055/s-2007-1006987
  19. Su YH, 2005, J NEUROPATH EXP NEUR, V64, P991, DOI 10.1097/01.jnen.0000187051.74265.56